top of page

Imexa Powder for oral Suspension 200mg/5ml

Product details

Registration number: SIN14282P

Classification: Prescription Only

Active ingredients: Azithromycin Dihydrate 210mg eq to Azithromycin

Strength: 200mg/5ml

Dosage form: POWDER, FOR SUSPENSION

Route: ORAL

Registrant: APEX PHARMA MARKETING PTE. LTD.

ATC code: J01FA10

HSA approval date: 31 December 2012

Manufacturer(s): Xepa-Soul Pattinson (Malaysia) Sdn Bhd

Manufacturing country/countries: MALAYSIA

What are the HSA registration number and classification for Imexa Powder for oral Suspension 200mg/5ml?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14282P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Imexa Powder for oral Suspension 200mg/5ml?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Azithromycin Dihydrate 210mg eq to Azithromycin

Strength: 200mg/5ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Imexa Powder for oral Suspension 200mg/5ml?

According to the HSA dataset updated 7 August 2026:

Dosage form: POWDER, FOR SUSPENSION

Route: ORAL

Source for this answer

Who is the recorded registrant for Imexa Powder for oral Suspension 200mg/5ml?

According to the HSA dataset updated 7 August 2026:

Registrant: APEX PHARMA MARKETING PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for Imexa Powder for oral Suspension 200mg/5ml?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Xepa-Soul Pattinson (Malaysia) Sdn Bhd

Manufacturing country/countries: MALAYSIA

Source for this answer

Where can I look up Imexa Powder for oral Suspension 200mg/5ml in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14282P or the exact product name Imexa Powder for oral Suspension 200mg/5ml. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Imexa Powder for oral Suspension 200mg/5ml record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Imexa Powder for oral Suspension 200mg/5ml record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14282P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page